pancreatic tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Aged 18~80 years old male and female; 2) preoperative and intraoperative judgment of surgical feasibility of benign or malignant tumor of the region of pancrease and duodenum; 3) voluntary trial, legal agent informed consent.
Exclusion criteria
Exclusion criteria: 1. Preoperative evaluation: 1) refuse to participate in clinical trials; 2) follow-up could not be completed; 3) no surgical indications after MDT discussion; 4) severe heart and lung disease and diabetes; 5) preoperative total bilirubin was greater than 200 mg/dL; 6) preoperative serum albumin was less than 35g/L; 7) BMI was greater than 28; 8) history of abdominal surgery; 9) application of somatostatin drugs before surgery; 10) borderline resectable tumor. 2. Intraoperative evaluation: 1) the operation time is more than 6 hours; 2) intraoperative blood loss was greater than 1000ml; 3) a fat pancreas; 4) main pancreatic duct diameter 15mm.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Culture of the bacterial and fungi of the drainage tube ;Oral semi-liquid diet time ;after surgery if puncture drainage is required ;reoperation;Postoperative bleeding ;abdominal infection;delayed gastric emptying ;Length of stay;readmission; | — |
Secondary
| Measure | Time frame |
|---|---|
| temperature;amylase of peritoneal drainage;Postoperative CT imaging findings; | — |
Countries
China
Contacts
Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine